Although follow-up studies will have to provide more detailed insights into the exact mechanisms, both the identification of ZEB2 and its downstream signals offer potential new therapeutic opportunities for patients suffering from ischemic heart disease. Here, ZEB2 is linked to coronary artery disorder.